FSZ - ETF AI Analysis

Top Page

First Trust Switzerland AlphaDEX Fund (FSZ)

Rating:60Neutral

Price Target:―

The First Trust Switzerland AlphaDEX Fund (FSZ) has a balanced overall rating, reflecting both strengths and challenges among its top holdings. BELIMO Holding AG stands out as a strong contributor due to its robust financial performance and strategic growth, although its high valuation and bearish momentum slightly temper its impact. On the other hand, Helvetia Holding AG and Novartis face profitability and cash flow challenges, which may have weighed on the ETF's rating. A key risk factor is the fund's exposure to companies with mixed financial and technical outlooks, which could lead to uneven performance.

Positive Factors

Strong Year-to-Date Performance

The ETF has delivered solid gains so far this year, indicating strong overall momentum.

Sector Diversification

The fund is spread across multiple sectors, including financials, health care, and industrials, reducing reliance on any single industry.

Focused Geographic Exposure

With a heavy focus on Switzerland, the ETF provides targeted exposure to a stable and developed market.

Negative Factors

High Expense Ratio

The ETF charges a relatively high fee compared to many other funds, which can eat into investor returns over time.

Underperforming Holdings

Some top holdings, such as Holcim and SFS Group AG, have lagged in performance, which may weigh on the fund's overall returns.

Limited Geographic Diversification

The ETF is heavily concentrated in Switzerland, offering little exposure to other global markets and increasing country-specific risk.

FSZ vs. SPDR S&P 500 ETF (SPY)

AUM43.14M

RegionEurope

Expense Ratio0.80%

Beta0.64

IssuerFirst Trust

Inception DateFeb 14, 2012

Dividend Yield1.84%

Asset ClassEquity

Index TrackedNASDAQ AlphaDEX Switzerland Index

Share Statistics

EPS (TTM)N/A

Shares OutstandingN/A

10 Day Avg. Volume892

30 Day Avg. Volume11,204

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

82.89

Price Target Upside― Downside

Rating ConsensusHold

Number of Analyst Covering39

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

FSZ Summary

The First Trust Switzerland AlphaDEX Fund (FSZ) is an ETF that focuses on Swiss companies using a unique rules-based approach to select stocks with strong growth and value potential. It includes well-known companies like Holcim and The Swatch Group, and covers industries such as finance, healthcare, and consumer goods. Investors might consider FSZ for diversification and exposure to the stable and innovative Swiss market. However, new investors should be aware that the ETF’s performance is closely tied to the Swiss economy, which means it can be affected by changes in the region’s economic conditions.

How much will it cost me?The expense ratio for the First Trust Switzerland AlphaDEX Fund (FSZ) is 0.8%, which means you’ll pay $8 per year for every $1,000 invested. This is higher than the average for ETFs because it is actively managed, using a rules-based strategy to select stocks with growth and value potential. Actively managed funds typically have higher costs due to the additional research and management involved.

What would affect this ETF?The FSZ ETF, which focuses on Swiss equities, could benefit from Switzerland's strong reputation for economic stability and innovation, particularly in sectors like healthcare and finance. Positive trends such as advancements in pharmaceuticals or growth in financial services could drive the ETF's performance. However, potential risks include economic slowdowns in Europe, regulatory changes affecting key sectors, or global market volatility, which could negatively impact the ETF's holdings and overall returns.

FSZ Top 10 Holdings

The First Trust Switzerland AlphaDEX Fund (FSZ) leans heavily into Switzerland’s financial and industrial sectors, with notable contributions from companies like Swissquote and Sandoz. Swissquote’s robust revenue growth and profitability are helping drive the fund forward, while Sandoz is riding strong technical momentum despite valuation concerns. On the flip side, names like Swatch and BELIMO are lagging, with bearish trends and profitability challenges holding back performance. Overall, FSZ’s focus on Swiss equities provides a mix of steady growth and defensive stability, though some holdings are struggling to keep pace.

Name	Company Name	Weight %	Market Value	Market Cap	Yearly Gain	Overall Rating
HOLN	Holcim	5.15%	$2.13M	CHF40.70B	-16.18%	73 Outperform
AVOL	Avolta AG	4.32%	$1.79M	CHF6.57B	25.10%	66 Neutral
HBAN	Helvetia Holding AG	4.27%	$1.77M	CHF19.70B	35.38%	59 Neutral
SDZ	Sandoz Group Ltd	4.25%	$1.76M	CHF25.32B	75.50%	59 Neutral
SQN	Swissquote Group Holding Ltd.	4.23%	$1.75M	CHF7.02B	38.88%	62 Neutral
UHR	The Swatch Group	4.09%	$1.69M	CHF8.53B	11.80%	61 Neutral
EFGN	EFG International AG	4.01%	$1.66M	CHF5.54B	71.15%	64 Neutral
SFSN	SFS Group AG	3.96%	$1.64M	CHF4.17B	-14.49%	72 Outperform
BEAN	BELIMO Holding AG	3.91%	$1.62M	CHF9.67B	50.20%	70 Outperform
	―	3.83%	$1.58M	―	―	―

FSZ Technical Analysis

Technical Analysis Sentiment

Positive

Last Price―

Price Trends

50DMA

76.83

Positive

100DMA

77.36

Positive

200DMA

74.44

Positive

Market Momentum

MACD

0.29

Negative

RSI

61.22

Neutral

STOCH

77.37

Neutral

Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For FSZ, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 76.79, equal to the 50-day MA of 76.83, and equal to the 200-day MA of 74.44, indicating a bullish trend. The MACD of 0.29 indicates Negative momentum. The RSI at 61.22 is Neutral, neither overbought nor oversold. The STOCH value of 77.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for FSZ.

FSZ Peer Comparison

Comparison Results

Name	Price	Price Target	AUM	Expense Ratio	Overall Rating
FSZ	―	―	$43.14M	0.80%	―
EWL	―	―	$1.51B	0.50%	―
FEUZ	―	―	$88.59M	0.80%	―
EUDG	―	―	$85.63M	0.58%	―
FGM	―	―	$80.49M	0.80%	―
FLSW	―	―	$60.80M	0.09%	―

Performance Comparison

FSZ

First Trust Switzerland AlphaDEX Fund

78.25

15.21

24.13%

EWL

iShares MSCI Switzerland ETF

―

FEUZ

First Trust Eurozone AlphaDEX ETF

―

EUDG

WisdomTree Europe Quality Dividend Growth Fund

―

FGM

First Trust Germany AlphaDEX Fund

―

FLSW

Franklin FTSE Switzerland ETF

―

Glossary

BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―

Table of Contents